Onderneming Revive Therapeutics Ltd Toronto S.E.
Aandelen
RVV
CA7615161030
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- CAD | -.--% |
|
+6,67% | -11,11% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 18-12-19 |
Carmelo Marrelli
DFI | Director of Finance/CFO | 53 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 18-12-19 |
William Jackson
BRD | Director/Board Member | - | 01-01-14 |
Andrew Lindzon
BRD | Director/Board Member | 63 | 18-12-19 |
Director/Board Member | 50 | 18-12-19 | |
Joshua Herman
BRD | Director/Board Member | - | 18-12-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 418 564 269 | 412 444 735 ( 98,54 %) | 0 | 98,54 % |
Bedrijfsgegevens
Revive Therapeutics Ltd.
The Canadian Venture Building 82 Richmond Street East
M5C 1P1, Toronto
+888-901-0036
http://www.revivethera.com![Adres Revive Therapeutics Ltd(RVV)](https://cdn.zonebourse.com/static/address/18313352.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,45% | 122 mld. | |
+21,96% | 116 mld. | |
+23,73% | 27,03 mld. | |
-20,05% | 20,36 mld. | |
-16,28% | 15,91 mld. | |
-16,52% | 16,43 mld. | |
-44,35% | 15,6 mld. | |
+63,91% | 14,94 mld. | |
+2,52% | 13,59 mld. |